Related Experiment Video
Updated: Aug 29, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth
Li Hao1, Min Du, Ana Lopez-Campistrous
1Department of Biochemistry, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
Matrix metalloproteinase (MMP)-dependent shedding of heparin-binding epidermal growth factor (HB-EGF) and subsequent activation of the EGF receptor (EGFR) in the cardiovasculature is emerging as a unique mechanism signaling growth effects of diverse G protein-coupled receptors (GPCRs). Among these GPCRs are adrenoceptors and angiotensin receptors that contribute to the pathogenesis of hypertension through their vasoconstrictive and growth effects. Focusing on alpha(1b)-adrenoceptors, we suggest here that MMP-dependent activation of the EGFR promotes vasoconstriction as well as growth. We identified MMP-7 as a major HB-EGF sheddase in rat mesenteric arteries and alpha(1b)-adrenoceptors, angiotensin receptors, and hypertension-stimulated MMP-7 activity. Adrenoceptors stimulated EGFR autophosphorylation in arteries, and this transactivation was opposed by the MMP-7 inhibitor GM6001 as well as MMP-7-specific antibodies. In isolated microperfused arteries, blockade of EGFR transactivation with inhibitors of the EGFR (AG1478 and PD153035), HB-EGF (CRM197 and neutralizing antibodies), or MMPs (doxycycline) inhibited adrenergic vasoconstriction. In spontaneously hypertensive rats but not in normotensive rats, the inhibition of MMPs with doxycycline (19.2 mg/d from week 7 until week 12) reduced systolic blood pressure and attenuated HB-EGF shedding in the mesenteric arteries. These findings suggest a previously unknown mechanism of vasoregulation whereby agonists of certain GPCRs (such as adrenoceptors and angiotensin receptors) activate MMPs (such as MMP-7) that shed EGFR ligands (such as HB-EGF), which then activate the EGFR, thereby promoting vasoconstriction as well as growth. Because this mechanism is triggered by agonists typically overexpressed in hypertension, its blockade may have therapeutic potential for simultaneously inhibiting pathological vasoconstriction and growth in hypertensive disorders.
Insights
Matrix metalloproteinases (MMPs) shed heparin-binding epidermal growth factor (HB-EGF), activating the EGF receptor (EGFR) to promote vasoconstriction and growth. This pathway, linked to hypertension, offers a potential therapeutic target.
Area of Science:
- Cardiovascular Physiology
- Molecular Signaling
- Hypertension Pathogenesis
Background:
- G protein-coupled receptors (GPCRs), like adrenoceptors and angiotensin receptors, contribute to hypertension via vasoconstriction and growth.
- GPCR signaling can involve matrix metalloproteinase (MMP)-dependent shedding of heparin-binding epidermal growth factor (HB-EGF), leading to EGF receptor (EGFR) activation.
Purpose of the Study:
- To investigate the role of MMP-dependent HB-EGF shedding and EGFR activation in alpha(1b)-adrenoceptor-mediated vasoconstriction and growth.
- To determine if this mechanism is relevant in the context of hypertension.
Main Methods:
- Utilized rat mesenteric arteries and spontaneously hypertensive rats.
- Employed MMP-7 inhibitors, MMP-7 specific antibodies, EGFR inhibitors, and HB-EGF blocking agents.
- Administered doxycycline to inhibit MMPs in vivo and measured systolic blood pressure and HB-EGF shedding.
Main Results:
- Identified MMP-7 as a key HB-EGF sheddase in rat mesenteric arteries.
- Demonstrated that alpha(1b)-adrenoceptor stimulation leads to EGFR transactivation, which was blocked by MMP inhibitors and antibodies.
- In spontaneously hypertensive rats, MMP inhibition with doxycycline reduced blood pressure and HB-EGF shedding.
Conclusions:
- A novel vasoregulation mechanism involves GPCR agonists activating MMPs to shed EGFR ligands, promoting vasoconstriction and growth.
- This MMP-dependent EGFR transactivation pathway is implicated in hypertension.
- Blocking this pathway may offer a therapeutic strategy for hypertension by inhibiting both vasoconstriction and pathological growth.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Regulation of Angiogenesis and Blood Supply
GPCRs Regulate Adenylyl Cylase Activity
Two...
MAPK Signaling Cascades
Cell-matrix's Response to Mechanical Forces
Anchoring junctions mechanically attach a cell to the...
Mitogens and the Cell Cycle
